ATYR PHARMA INC (LIFE)

US0021202025 - Common Stock

1.985  +0.02 (+0.76%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to LIFE. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 23.66. This target is 1092.14% above the current price.
LIFE was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about LIFE.
In the previous month the buy percentage consensus was at a similar level.
LIFE was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 1.9912.1220.4023.6636.75 - 510.58% 927.71% 1,092.14% 1,751.39%
Up and Down Grades
Date Firm Action Rating
2024-02-21 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-21 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-14 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-10 HC Wainwright & Co. Reiterate Buy -> Buy
2023-07-21 Piper Sandler Maintains Overweight -> Overweight
2023-07-05 Oppenheimer Downgrade Outperform -> Perform
2023-05-23 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-10 RBC Capital Reiterate Outperform
2023-04-11 Piper Sandler Maintains Overweight
2023-03-10 RBC Capital Reiterate Outperform
2023-03-10 HC Wainwright & Co. Reiterate Buy
2023-03-06 Roth MKM Reiterate Buy
2023-03-02 RBC Capital Maintains Outperform
2023-02-07 HC Wainwright & Co. Reiterate Buy
2022-08-16 Piper Sandler Maintains Overweight
2022-07-21 HC Wainwright & Co. Maintains Buy
2022-05-18 Piper Sandler Maintains Overweight
2022-05-10 RBC Capital Maintains Outperform
2021-11-11 HC Wainwright & Co. Maintains Buy
2021-10-12 RBC Capital Initiate Outperform
2021-09-21 Piper Sandler Initiate Overweight
2021-09-14 Oppenheimer Maintains Outperform
2021-09-14 Roth Capital Maintains Buy
2021-09-13 HC Wainwright & Co. Maintains Buy
2021-05-18 JonesTrading Initiate Buy
2021-03-24 Oppenheimer Maintains Outperform
2021-03-16 Roth Capital Maintains Buy